HSA-2023-0072-V272

Type IB variation for application HSA-2023-0072. Type IB variation: Formulation Change for Verasenib — critical change

Variation Number
HSA-2023-0072-V272
Type
Type IB
Application
HSA-2023-0072
Change
CHG-2021-0272
Status
Blocked
Fee
€1,024
Submitted
2022-12-09
Approved
—
Description

Type IB variation: Formulation Change for Verasenib — critical change